{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T11:25:28Z","timestamp":1786879528407,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences","doi-asserted-by":"publisher","award":["1404-5-499-92729"],"award-info":[{"award-number":["1404-5-499-92729"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.neurol.2026.04.008","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T20:42:50Z","timestamp":1780519370000},"page":"600-608","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Novel variants and rare clinical presentations in MFN2-related Charcot-Marie-Tooth disease: Insights from 10 families"],"prefix":"10.1016","volume":"182","author":[{"given":"H.","family":"Gharebaghian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ravanbod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ghasemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Asghar","family":"Okhovat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Nafissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Alavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.neurol.2026.04.008_bib0160","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00415-014-7490-9","article-title":"Charcot Marie Tooth disease (CMT): historical perspectives and evolution","volume":"262","author":"Kazamel","year":"2015","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2026.04.008_bib0165","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.3390\/biom14091138","article-title":"Current treatment methods for Charcot-Marie-Tooth diseases","author":"Dong","year":"2024","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.neurol.2026.04.008_bib0170","first-page":"290","article-title":"Clinical practice guidelines for the diagnosis and management of Charcot-Marie-Tooth disease","volume":"40","author":"Sivera Mascaro","year":"2025","journal-title":"Neurolog\u00eda"},{"issue":"14","key":"10.1016\/j.neurol.2026.04.008_bib0175","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.3390\/ijms20143419","article-title":"From molecules to therapy","volume":"20","author":"Morena","year":"2019","journal-title":"I J Mol Sci"},{"issue":"9","key":"10.1016\/j.neurol.2026.04.008_bib0180","doi-asserted-by":"crossref","first-page":"e18293","DOI":"10.1111\/jcmm.18293","article-title":"Charcot-Marie-Tooth type 2A in vivo models: current updates","volume":"28","author":"Abati","year":"2024","journal-title":"J Cell Mol Med"},{"issue":"2","key":"10.1016\/j.neurol.2026.04.008_bib0185","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1212\/WNL.0b013e3182242d4d","article-title":"Recessive axonal Charcot-Marie-Tooth disease due to compound heterozygous mitofusin 2 mutations","volume":"77","author":"Polke jm","year":"2011","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.neurol.2026.04.008_bib0190","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1002\/ajmg.a.37611","article-title":"Autosomal recessive MFN2-related Charcot-Marie-Tooth disease with diaphragmatic weakness: case report and literature review","volume":"170","author":"Tan","year":"2016","journal-title":"Am J Med Genet A"},{"issue":"12","key":"10.1016\/j.neurol.2026.04.008_bib0195","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1093\/brain\/awaa323","article-title":"Natural history of Charcot-Marie-Tooth disease type 2A: a large international multicentre study","volume":"143","author":"Pipis","year":"2020","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.neurol.2026.04.008_bib0200","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"6","key":"10.1016\/j.neurol.2026.04.008_bib0205","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1159\/000531507","article-title":"Copy number variations in hereditary spastic paraplegia-related genes: evaluation of an iranian hereditary spastic paraplegia cohort and literature review","volume":"14","author":"Ghasemi","year":"2023","journal-title":"Mol Syndromol"},{"key":"10.1016\/j.neurol.2026.04.008_bib0210","doi-asserted-by":"crossref","first-page":"106467","DOI":"10.1016\/j.nbd.2024.106467","article-title":"Charcot-Marie-tooth disease type 2A: an update on pathogenesis and therapeutic perspectives","volume":"193","author":"Alberti","year":"2024","journal-title":"Neurobiol Dis"},{"issue":"2","key":"10.1016\/j.neurol.2026.04.008_bib0215","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1523\/JNEUROSCI.4798-06.2007","article-title":"Altered axonal mitochondrial transport in the pathogenesis of Charcot-Marie-Tooth disease from mitofusin 2 mutations","volume":"27","author":"Baloh","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurol.2026.04.008_bib0220","doi-asserted-by":"crossref","first-page":"858286","DOI":"10.3389\/fcell.2022.858286","article-title":"The role of impaired mitochondrial dynamics in MFN2-mediated pathology","volume":"10","author":"Zaman","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.neurol.2026.04.008_bib0225","doi-asserted-by":"crossref","unstructured":"Shumeri E, Mandorah E, Martini N, Boyer A, Halbert C, Puma A, et al. Digenesis in Charcot\u2013Marie\u2013Tooth Disease: Impact of Combined Mutations in the MFN2 and GDAP1 Genes. J Peripher Nerv Syst 30(3):e70044. DOI10.1111\/jns.70044.","DOI":"10.1111\/jns.70044"},{"key":"10.1016\/j.neurol.2026.04.008_bib0230","doi-asserted-by":"crossref","unstructured":"Zhang Y, Pang D, Wang Z, Ma L, Chen Y, Yang L, et al. An integrative analysis of genotype-phenotype correlation in Charcot Marie Tooth type 2A disease with MFN2 variants: A case and systematic review. Gene 883:147684, DOI.10.1016\/j.gene.2023.147684.","DOI":"10.1016\/j.gene.2023.147684"},{"key":"10.1016\/j.neurol.2026.04.008_bib0235","doi-asserted-by":"crossref","first-page":"606","DOI":"10.12688\/f1000research.53230.2","article-title":"Characterization of a novel variant in the HR1 domain of MFN2 in a patient with ataxia, optic atrophy and sensorineural hearing loss","volume":"10","author":"Sharma","year":"2022","journal-title":"F1000Res"},{"key":"10.1016\/j.neurol.2026.04.008_bib0240","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddv229","article-title":"Homozygous mutations in MFN2 cause multiple symmetric lipomatosis associated with neuropathy","author":"Sawyer","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurol.2026.04.008_bib0245","doi-asserted-by":"crossref","unstructured":"A. D\u2019Amore, Tessa A, Casali C, Dotti MT, Filla A, Silvestri G, et al. Next generation molecular diagnosis of hereditary spastic paraplegias: an Italian cross-sectional study. Front Neurol 4:9:981. DOI.10.3389\/fneur.2018.00981.","DOI":"10.3389\/fneur.2018.00981"},{"key":"10.1016\/j.neurol.2026.04.008_bib0250","first-page":"14","article-title":"Case report: Asp194Ala variant in MFN2 is associated with ALS-FTD in an Italian family","volume":"20","author":"Vinciguerra","year":"2023","journal-title":"Front Genet"},{"issue":"3","key":"10.1016\/j.neurol.2026.04.008_bib0255","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/cge.13881","article-title":"Genetic spectrum of Charcot-Marie-Tooth disease associated with myelin protein zero gene variants in Japan","volume":"99","author":"Taniguchi","year":"2021","journal-title":"Clin Genet"},{"key":"10.1016\/j.neurol.2026.04.008_bib0260","article-title":"Mutated mitofusin 2 presents with intrafamilial variability and brain mitochondrial dysfunction","author":"Del Bo","year":"2008","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.neurol.2026.04.008_bib0265","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.nmd.2011.03.008","article-title":"Characterizing the phenotypic manifestations of MFN2 R104W mutation in Charcot-Marie-Tooth type 2","volume":"21","author":"Genari","year":"2011","journal-title":"Neuromuscul Disord"},{"issue":"11","key":"10.1016\/j.neurol.2026.04.008_bib0270","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.2169\/internalmedicine.6487-20","article-title":"An MFN2-related Charcot-Marie-Tooth disease patient with optic nerve atrophy, neurogenic bladder dysfunction, and diaphragmatic weakness","volume":"61","author":"Kimura","year":"2022","journal-title":"Inter Med"},{"issue":"2","key":"10.1016\/j.neurol.2026.04.008_bib0275","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.nmd.2018.12.008","article-title":"A novel MFN2 mutation causes variable clinical severity in a multi-generational CMT2 family","volume":"29","author":"Dankwa","year":"2019","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.neurol.2026.04.008_bib0280","article-title":"A novel founder mutation in the MFN2 gene associated with variable Charcot-Marie-Tooth type 2 phenotype in two families from Southern Italy","volume":"2009","author":"Muglia","year":"2009","journal-title":"BMJ Case Rep"},{"issue":"10","key":"10.1016\/j.neurol.2026.04.008_bib0285","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/archneurol.2011.225","article-title":"Large Kindred evaluation of mitofusin 2 novel mutation, extremes of neurologic presentations, and preserved nerve mitochondria","volume":"68","author":"Klein","year":"2011","journal-title":"Arch Neurol"},{"issue":"7","key":"10.1016\/j.neurol.2026.04.008_bib0290","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00415-008-0847-1","article-title":"Cerebral involvement in axonal Charcot-Marie-Tooth neuropathy caused by mitofusin2 mutation","volume":"255","author":"Brockmann","year":"2008","journal-title":"J Neurol"},{"issue":"6","key":"10.1016\/j.neurol.2026.04.008_bib0295","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/cge.12432","article-title":"A cohort study of MFN2 mutations and phenotypic spectrums in Charcot-Marie-Tooth disease 2A patients","volume":"87","author":"Choi","year":"2015","journal-title":"Clin Genet"},{"issue":"5","key":"10.1016\/j.neurol.2026.04.008_bib0300","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/13685538.2018.1491543","article-title":"Urogenital dysfunction in male patients with Charcot-Marie-Tooth: a systematic review","volume":"23","author":"Cannarella","year":"2020","journal-title":"Aging Male"},{"key":"10.1016\/j.neurol.2026.04.008_bib0305","doi-asserted-by":"crossref","DOI":"10.1159\/000117029","article-title":"Impotence associated with the Charcot-Marie-Tooth syndrome","author":"Bird","year":"2008","journal-title":"Eur Neurol"},{"issue":"9","key":"10.1016\/j.neurol.2026.04.008_bib0310","doi-asserted-by":"crossref","first-page":"582","DOI":"10.5692\/clinicalneurol.49.582","article-title":"Predominant parasympathetic involvement in a patient with Charcot-Marie-Tooth disease caused by the MPZ Thr124Met mutation (in jpn)","volume":"49","author":"Nakamura","year":"2009","journal-title":"Rinsho Shinkeigaku"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003537872600528X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003537872600528X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T10:45:24Z","timestamp":1786877124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003537872600528X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S003537872600528X"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2026.04.008","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel variants and rare clinical presentations in MFN2-related Charcot-Marie-Tooth disease: Insights from 10 families","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2026.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}